Warren Pleskow

1.5k total citations
23 papers, 966 citations indexed

About

Warren Pleskow is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Warren Pleskow has authored 23 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Pharmacology. Recurrent topics in Warren Pleskow's work include Asthma and respiratory diseases (19 papers), Drug-Induced Adverse Reactions (9 papers) and Respiratory and Cough-Related Research (8 papers). Warren Pleskow is often cited by papers focused on Asthma and respiratory diseases (19 papers), Drug-Induced Adverse Reactions (9 papers) and Respiratory and Cough-Related Research (8 papers). Warren Pleskow collaborates with scholars based in United States, Switzerland and Bulgaria. Warren Pleskow's co-authors include Donald D. Stevenson, Robert S. Zeiger, Michael Schätz, William R. Lumry, R. A. Simon, Randy Simon, Harold S. Nelson, Andre van As, Michael Noonan and Edwin A. Bronsky and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Annals of Allergy Asthma & Immunology and Journal of Asthma.

In The Last Decade

Warren Pleskow

23 papers receiving 892 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Warren Pleskow United States 13 738 461 395 135 77 23 966
Rodger Kempsford United Kingdom 16 416 0.6× 388 0.8× 12 0.0× 25 0.2× 48 0.6× 44 629
Junichiro Mifune Japan 10 168 0.2× 138 0.3× 38 0.1× 14 0.1× 13 0.2× 45 488
J. P. Griffin United Kingdom 13 102 0.1× 135 0.3× 34 0.1× 6 0.0× 32 0.4× 32 458
H. Van Cauwenberge Belgium 10 45 0.1× 101 0.2× 38 0.1× 13 0.1× 3 0.0× 44 373
A. Macciocchi Switzerland 15 599 0.8× 33 0.1× 168 0.4× 2 0.0× 24 1.4k
DA Richards United States 10 56 0.1× 41 0.1× 64 0.2× 9 0.1× 32 0.4× 21 367
Géraldine Cohuet Italy 11 889 1.2× 1.1k 2.4× 20 0.1× 6 0.0× 4 0.1× 20 1.4k
I. Scaricabarozzi Italy 13 84 0.1× 42 0.1× 178 0.5× 7 0.1× 48 423
R R Ghose United Kingdom 9 47 0.1× 71 0.2× 26 0.1× 28 0.2× 3 0.0× 34 366
J. K. McKenzie Canada 12 64 0.1× 95 0.2× 43 0.1× 2 0.0× 19 0.2× 24 586

Countries citing papers authored by Warren Pleskow

Since Specialization
Citations

This map shows the geographic impact of Warren Pleskow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warren Pleskow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warren Pleskow more than expected).

Fields of papers citing papers by Warren Pleskow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Warren Pleskow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warren Pleskow. The network helps show where Warren Pleskow may publish in the future.

Co-authorship network of co-authors of Warren Pleskow

This figure shows the co-authorship network connecting the top 25 collaborators of Warren Pleskow. A scholar is included among the top collaborators of Warren Pleskow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Warren Pleskow. Warren Pleskow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pascoe, Steven, Christine Reynolds, Warren Pleskow, et al.. (2011). Safety, tolerability and pharmacokinetics of single escalating doses of indacaterol, a once-daily beta2-agonist bronchodilator, in subjects with COPD. International Journal of Clinical Pharmacology and Therapeutics. 49(2). 153–161. 10 indexed citations
2.
Nair, Parameswaran, Jonathan Corren, Warren Pleskow, et al.. (2008). A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects. Journal of Allergy and Clinical Immunology. 122(3). 544–549. 8 indexed citations
3.
Pleskow, Warren, et al.. (2005). Pairwise comparison of levalbuterol versus racemic albuterol in the treatment of moderate-to-severe asthma.. PubMed. 25(6). 429–36. 15 indexed citations
4.
5.
Galant, Stanley P., Julius van Bavel, Albert F. Finn, et al.. (1999). Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma. Annals of Allergy Asthma & Immunology. 82(3). 273–280. 25 indexed citations
6.
Nelson, Harold S., George Bensch, Warren Pleskow, et al.. (1998). Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma☆☆☆★★★. Journal of Allergy and Clinical Immunology. 102(6). 943–952. 153 indexed citations
7.
Ramsdell, Joe, et al.. (1998). A Controlled Trial of Twice Daily Triamcinolone Oral Inhaler in Patients with Mild-to-Moderate Asthma. Annals of Allergy Asthma & Immunology. 80(5). 385–390. 8 indexed citations
8.
Guthrie, Robert, et al.. (1998). Efficacy and Tolerability of Irbesartan, an Angiotensin II Receptor Antagonist, in Primary Hypertension. Clinical Drug Investigation. 15(3). 217–227. 24 indexed citations
9.
Adelglass, Jeffrey, Thomas B. Casale, Robert M. Cohen, et al.. (1996). Intranasal therapy with once-daily triamcinolone acetonide aerosol versus twice-daily beclomethasone dipropionate aqueous spray in patients with perennial allergic rhinitis. Current Therapeutic Research. 57(11). 825–838. 3 indexed citations
10.
Munk, Zev M., David S. Pearlman, David F. Graft, et al.. (1994). Intranasal Fluticasone Propionate Is Effective and Well-Tolerated in Adolescents with Seasonal Allergic Rhinitis. Pediatric Asthma Allergy & Immunology. 8(1). 39–46. 13 indexed citations
11.
Chervinsky, Paul, Andre van As, Edwin A. Bronsky, et al.. (1994). Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. Journal of Allergy and Clinical Immunology. 94(4). 676–683. 137 indexed citations
12.
Chervinsky, Paul, Edwin A. Bronsky, Robert J. Dockhorn, et al.. (1991). 464 Fluticasone propionate (FP) aerosol in asthma. Journal of Allergy and Clinical Immunology. 87(1). 255–255. 7 indexed citations
13.
Pleskow, Warren, William R. Lumry, & R. A. Simon. (1984). Zomepirac sodium (Zomax) hypersensitivity in aspirin-sensitive asthmatics.. PubMed. 130(6). 1170–3. 4 indexed citations
14.
Stevenson, Donald D., Warren Pleskow, R. A. Simon, et al.. (1984). Aspirin-sensitive rhinosinusitis asthma: A double-blind crossover study of treatment with aspirin. Journal of Allergy and Clinical Immunology. 73(4). 500–507. 165 indexed citations
15.
Simon, R. A., Warren Pleskow, Michael Kaliner, et al.. (1983). 232 Plasma mediator studies in aspirin sensitive asthma: Lack of a role for the mast cell. Journal of Allergy and Clinical Immunology. 71(1). 146–146. 7 indexed citations
16.
Pleskow, Warren, Dennis E. Chenoweth, Ronald A. Simon, Donald D. Stevenson, & John G. Curd. (1983). The absence of detectable complement activation in aspirin-sensitive asthmatic patients during aspirin challenge. Journal of Allergy and Clinical Immunology. 72(5). 462–468. 15 indexed citations
17.
Lumry, William R., John G. Curd, Robert S. Zeiger, Warren Pleskow, & Donald D. Stevenson. (1983). Aspirin sensitive rhinosinusitis: the clinical syndrome and effects of aspirin administration. Journal of Allergy and Clinical Immunology. 71(6). 580–587. 65 indexed citations
18.
Pleskow, Warren, et al.. (1983). 24 Lack of histamine release by anti-IgG, IgG1, IgG2, and IgG4 antibodies from leukocytes of allergic donors with low IgE levels. Journal of Allergy and Clinical Immunology. 71(1). 94–94. 1 indexed citations
19.
Pleskow, Warren, Donald D. Stevenson, David A. Mathison, et al.. (1983). Aspirin-sensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirin. Journal of Allergy and Clinical Immunology. 71(6). 574–579. 100 indexed citations
20.
Pleskow, Warren, et al.. (1982). Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period. Journal of Allergy and Clinical Immunology. 69(1). 11–19. 157 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rodger Kempsford Breakdown of academic impact, for papers by Junichiro Mifune Breakdown of academic impact, for papers by J. P. Griffin Breakdown of academic impact, for papers by H. Van Cauwenberge Breakdown of academic impact, for papers by A. Macciocchi Breakdown of academic impact, for papers by DA Richards Breakdown of academic impact, for papers by Géraldine Cohuet Breakdown of academic impact, for papers by I. Scaricabarozzi Breakdown of academic impact, for papers by R R Ghose Breakdown of academic impact, for papers by J. K. McKenzie
Rankless by CCL
2026